Archives: Search / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015
2008 Archives
Philadelphia, PA – December 16, 2008 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food... More |
Company Enters Pain Management Market with Topical Anesthetic Philadelphia, PA – December 11, 2008 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced it has launched a certain topical anesthetic product... More |
Company Appoints Jeffrey Farber as Interim Chairman Philadelphia, PA, September 10, 2008: Lannett Company Inc. (AMEX: LCI) today announced that William Farber, the company’s chairman since 1991, has taken a temporary leave of absence for health... More |
Philadelphia, PA – August 1, 2008 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approvals from the U.S. Food and... More |
Company to Enter Pain Management Market
|
Philadelphia, PA – June 2, 2008 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today said that it expects to commence marketing Amantadine Hydrochloride... More |
Philadelphia, PA – May 15, 2008 – Lannett Company, Inc. (AMEX: LCI) today reported financial results for the fiscal 2008 third quarter and nine months ended March 31, 2008. For the... More |
Estate Planning Move Ensures Continuity of Ownership Philadelphia, PA – May 9, 2008 – Lannett Company, Inc. (AMEX: LCI) announced today its chairman, William Farber, has sold five million shares of Lannett Company common stock to Farber... More |
Philadelphia, PA – April 30, 2008 – Lannett Company, Inc. (AMEX: LCI) today said it will continue to market its Digoxin Tablets and that the company’s Digoxin product is not subject... More |
Philadelphia, PA – April 24, 2008 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and... More |
Philadelphia, PA – March 31, 2008 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and... More |
Philadelphia, PA – February 13, 2008 – Lannett Company, Inc. (AMEX: LCI) today announced that the company will present at the ROTH 20th Annual Growth Stock Conference Wednesday,... More |
Philadelphia, PA – February 11, 2008 – Lannett Company, Inc. (AMEX: LCI) today said it is encouraged by a legal development in Florida that could remove generic Levothyroxine Sodium... More |